- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA.3: 1 residues within 4Å:- Chain A: N.127
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.6: 3 residues within 4Å:- Chain A: N.215, T.217, F.218
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.9: 3 residues within 4Å:- Chain A: N.261, T.263, N.264
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.10: 6 residues within 4Å:- Chain A: G.253, E.254, N.274, E.275, R.328, K.331
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:R.328, A:R.328, A:K.331
NAG-NAG-BMA.12: 6 residues within 4Å:- Chain A: E.319, N.323, R.376, S.388, E.390
- Ligands: NAG-NAG-BMA.14
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.14: 4 residues within 4Å:- Chain A: N.375
- Ligands: NAG-NAG-BMA.12, NAG-NAG-BMA-MAN-MAN-MAN-MAN.13, NAG-NAG-BMA-MAN-MAN-MAN-MAN.13
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.15: 2 residues within 4Å:- Chain A: N.431
- Ligands: NAG-NAG-BMA-MAN-MAN.8
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.19: 1 residues within 4Å:- Chain C: N.127
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.22: 3 residues within 4Å:- Chain C: N.215, T.217, F.218
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.25: 3 residues within 4Å:- Chain C: N.261, T.263, N.264
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.26: 6 residues within 4Å:- Chain C: G.253, E.254, N.274, E.275, R.328, K.331
3 PLIP interactions:3 interactions with chain C- Hydrogen bonds: C:R.328, C:R.328, C:K.331
NAG-NAG-BMA.28: 6 residues within 4Å:- Chain C: E.319, N.323, R.376, S.388, E.390
- Ligands: NAG-NAG-BMA.30
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.30: 4 residues within 4Å:- Chain C: N.375
- Ligands: NAG-NAG-BMA.28, NAG-NAG-BMA-MAN-MAN-MAN-MAN.29, NAG-NAG-BMA-MAN-MAN-MAN-MAN.29
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.31: 2 residues within 4Å:- Chain C: N.431
- Ligands: NAG-NAG-BMA-MAN-MAN.24
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.35: 1 residues within 4Å:- Chain E: N.127
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.38: 4 residues within 4Å:- Chain E: N.215, T.217, F.218, T.219
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.41: 3 residues within 4Å:- Chain E: N.261, T.263, N.264
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.42: 6 residues within 4Å:- Chain E: G.253, E.254, N.274, E.275, R.328, K.331
4 PLIP interactions:4 interactions with chain E- Hydrophobic interactions: E:E.254
- Hydrogen bonds: E:R.328, E:R.328, E:K.331
NAG-NAG-BMA.44: 6 residues within 4Å:- Chain E: E.319, N.323, R.376, S.388, E.390
- Ligands: NAG-NAG-BMA.46
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.46: 4 residues within 4Å:- Chain E: N.375
- Ligands: NAG-NAG-BMA.44, NAG-NAG-BMA-MAN-MAN-MAN-MAN.45, NAG-NAG-BMA-MAN-MAN-MAN-MAN.45
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA.47: 2 residues within 4Å:- Chain E: N.431
- Ligands: NAG-NAG-BMA-MAN-MAN.40
No protein-ligand interaction detected (PLIP)- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.5: 13 residues within 4Å:- Chain A: D.170, R.177, N.182, T.183
- Chain C: W.299
- Chain G: D.60
- Chain J: G.29, A.30, A.31, G.95, F.97, T.98, F.99
3 PLIP interactions:2 interactions with chain J, 1 interactions with chain G- Hydrophobic interactions: J:A.31
- Hydrogen bonds: J:A.30, J:A.31, G:D.60, J:S.2, J:S.2
NAG-NAG-BMA-MAN-MAN.21: 10 residues within 4Å:- Chain C: D.170, R.177, N.182, T.183
- Chain H: D.60
- Chain K: G.29, A.30, A.31, F.97, T.98
3 PLIP interactions:2 interactions with chain K, 1 interactions with chain H- Hydrogen bonds: K:A.30, K:A.31, H:D.60
NAG-NAG-BMA-MAN-MAN.37: 11 residues within 4Å:- Chain A: W.299
- Chain E: D.170, R.177, N.182, T.183
- Chain I: D.60
- Chain L: G.29, A.30, A.31, F.97, T.98
3 PLIP interactions:2 interactions with chain L, 1 interactions with chain I- Hydrogen bonds: L:A.30, L:A.31, I:D.60
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN.7: 4 residues within 4Å:- Chain A: E.77, N.214, N.225, N.226
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.23: 4 residues within 4Å:- Chain C: E.77, N.214, N.225, N.226
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN.39: 4 residues within 4Å:- Chain E: E.77, N.214, N.225, N.226
2 PLIP interactions:2 interactions with chain E- Hydrogen bonds: E:E.77, E:E.77
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.8: 10 residues within 4Å:- Chain A: S.194, D.196, P.197, N.247, C.361, C.428, I.429, S.430, N.431
- Ligands: NAG-NAG-BMA.15
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:D.196
- Hydrogen bonds: A:S.194, A:S.194, A:D.196
NAG-NAG-BMA-MAN-MAN.24: 9 residues within 4Å:- Chain C: S.194, D.196, P.197, N.247, C.361, I.429, S.430, N.431
- Ligands: NAG-NAG-BMA.31
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:D.196
- Hydrogen bonds: C:S.194, C:S.194, C:D.196
NAG-NAG-BMA-MAN-MAN.40: 9 residues within 4Å:- Chain E: S.194, D.196, P.197, N.247, C.361, I.429, S.430, N.431
- Ligands: NAG-NAG-BMA.47
3 PLIP interactions:3 interactions with chain E- Hydrophobic interactions: E:D.196
- Hydrogen bonds: E:S.194, E:S.194, E:D.196
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN-MAN-MAN.13: 8 residues within 4Å:- Chain A: L.352, N.369, S.371
- Chain G: D.113
- Chain J: R.47, W.57
- Ligands: NAG-NAG-BMA.14, NAG-NAG-BMA.14
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.29: 8 residues within 4Å:- Chain C: L.352, N.369, S.371
- Chain H: D.113
- Chain K: R.47, W.57
- Ligands: NAG-NAG-BMA.30, NAG-NAG-BMA.30
No protein-ligand interaction detected (PLIP)NAG-NAG-BMA-MAN-MAN-MAN-MAN.45: 9 residues within 4Å:- Chain E: L.352, N.369, S.371, R.402
- Chain I: D.113
- Chain L: R.47, W.57
- Ligands: NAG-NAG-BMA.46, NAG-NAG-BMA.46
No protein-ligand interaction detected (PLIP)- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.49: 3 residues within 4Å:- Chain A: T.129, K.140, N.141
Ligand excluded by PLIPNAG.50: 3 residues within 4Å:- Chain A: N.172, S.173, S.174
Ligand excluded by PLIPNAG.51: 4 residues within 4Å:- Chain A: P.284, N.286, I.307, G.308
Ligand excluded by PLIPNAG.52: 6 residues within 4Å:- Chain A: K.340, N.341, M.379, N.445, T.446
- Ligands: NAG-NAG.16
Ligand excluded by PLIPNAG.53: 3 residues within 4Å:- Chain A: N.425, I.426, T.427
Ligand excluded by PLIPNAG.54: 1 residues within 4Å:- Chain B: N.107
Ligand excluded by PLIPNAG.55: 2 residues within 4Å:- Chain B: N.114, E.117
Ligand excluded by PLIPNAG.56: 2 residues within 4Å:- Chain B: N.133, Y.134
Ligand excluded by PLIPNAG.57: 3 residues within 4Å:- Chain C: T.129, K.140, N.141
Ligand excluded by PLIPNAG.58: 3 residues within 4Å:- Chain C: N.172, S.173, S.174
Ligand excluded by PLIPNAG.59: 4 residues within 4Å:- Chain C: P.284, N.286, I.307, G.308
Ligand excluded by PLIPNAG.60: 6 residues within 4Å:- Chain C: K.340, N.341, M.379, N.445, T.446
- Ligands: NAG-NAG.32
Ligand excluded by PLIPNAG.61: 3 residues within 4Å:- Chain C: N.425, I.426, T.427
Ligand excluded by PLIPNAG.62: 1 residues within 4Å:- Chain D: N.107
Ligand excluded by PLIPNAG.63: 2 residues within 4Å:- Chain D: N.114, E.117
Ligand excluded by PLIPNAG.64: 2 residues within 4Å:- Chain D: N.133, Y.134
Ligand excluded by PLIPNAG.65: 3 residues within 4Å:- Chain E: K.140, N.141, N.158
Ligand excluded by PLIPNAG.66: 3 residues within 4Å:- Chain E: N.172, S.173, S.174
Ligand excluded by PLIPNAG.67: 4 residues within 4Å:- Chain E: P.284, N.286, I.307, G.308
Ligand excluded by PLIPNAG.68: 6 residues within 4Å:- Chain E: K.340, N.341, M.379, N.445, T.446
- Ligands: NAG-NAG.48
Ligand excluded by PLIPNAG.69: 3 residues within 4Å:- Chain E: N.425, I.426, T.427
Ligand excluded by PLIPNAG.70: 1 residues within 4Å:- Chain F: N.107
Ligand excluded by PLIPNAG.71: 2 residues within 4Å:- Chain F: N.114, E.117
Ligand excluded by PLIPNAG.72: 2 residues within 4Å:- Chain F: N.133, Y.134
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jia, M. et al., VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA. Cell Host Microbe (2020)
- Release Date
- 2020-05-06
- Peptides
- Glycoprotein 120: ACE
Glycoprotein 41: BDF
M1214 N1 Fab heavy chain: GHI
M1214 N1 Fab light chain: JKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
II
JJ
LK
ML
N
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 15 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 21 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN- MAN- MAN: alpha-D-mannopyranose-(1-3)-alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)-alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 24 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Jia, M. et al., VSV-Displayed HIV-1 Envelope Identifies Broadly Neutralizing Antibodies Class-Switched to IgG and IgA. Cell Host Microbe (2020)
- Release Date
- 2020-05-06
- Peptides
- Glycoprotein 120: ACE
Glycoprotein 41: BDF
M1214 N1 Fab heavy chain: GHI
M1214 N1 Fab light chain: JKL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
CE
EB
BD
DF
FG
HH
II
JJ
LK
ML
N